GlassScriptPhysician profile
Eugene C Rajaratnam
NPI 1386739027
$4,509.36
in general payments reported to CMS, 2019-2025
18 companies · $2,578 in 2025
The $2,578 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $192 · 2021: $366 · 2022: $754 · 2023: $126 · 2024: $215 · 2025: $2,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,904 · Food and Beverage: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,904.22 |
| Food and Beverage | $1,013.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $2,297.15 | 2019-2025 | S~Curve |
| Procept Biorobotics Corporation | $540.42 | 2022-2025 | |
| Pfizer INC. | $306.63 | 2019-2022 | |
| Olympus America INC. | $253.37 | 2025 | Itind System |
| Tolmar Pharmaceuticals, INC. | $193.94 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $163.96 | 2019-2024 | Xiaflex |
| Boston Scientific Corporation | $157.44 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $117.69 | 2025 | |
| Tempus Ai, INC | $115.61 | 2024 | |
| Angiodynamics, INC. | $103.69 | 2025 | Nanoknife |
| Tris Pharma INC | $80.09 | 2023 | Quillivant, Quillichew Er, Dyanavel Xr |
| Coloplast Corp | $39.80 | 2021-2022 | |
| Astellas Pharma US INC | $29.61 | 2024 | Xtandi |
| Myovant Sciences INC. | $27.49 | 2021 | |
| Accord Healthcare, INC. | $24.92 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $21.85 | 2024 | Bard Urinary Drainage Bag |
| Allergan, INC. | $21.13 | 2019 | |
| Tolmar, INC. | $14.57 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Rajaratnam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.